2/26/2014 9:12:38 AM
CAMBRIDGE, Mass., Feb. 26, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, announced its financial results and business highlights for the fourth-quarter and full-year of 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by